The Role of Purchasers in the Clinical Research Enterprise

Publisher Website
Google Scholar
Abstract
Recently, the investment in health care by companies has been increasing by roughly 8 to 10% per year. A common question that corporate shareholders ask is what the company will receive from an additional investment. Do the annual increases in health care expenditures buy better health, or even better health care? Or does this money simply buy more services, regardless of their value to the company/s beneficiaries? Will the substantial incremental investment in health care that many purchasers face somehow add to the bottom line of the enterprise or add to the public good? Or will the additional dollars be spent with no return?

This publication has 0 references indexed in Scilit: